Delivery Order SPE2DR25D3301-SPE2DR26F18AT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. The contract is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on August 29, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, with no set-aside designation applied. The contract represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on September 29, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) on August 21, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on October 31, 2025, with an ultimate completion date of November 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. Performance will...
- AmerisourceBergen Drug Corp was awarded a $17,968.39 delivery order by the Defense Logistics Agency on August 21, 2025, for the supply of Welireg 40 mg tablets (90-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open solicitation process. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is issued as a child contract under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18ATDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,935.93 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 5, 2025. The award was made on November 13, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for Welireg demonstrates the company's role in supplying oncological and specialized pharmaceutical treatments to support Defense Health Agency and other federal healthcare systems. The SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle, enabling flexible fulfillment of varied medical supply requirements across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 11/13/25 |